Striving for a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently.

Lobular Breast Cancer Videos

Watch our videos on research and advocacy

ILC vs IDC

What Is Invasive Lobular Carcinoma?

Invasive lobular carcinoma (ILC), also known as lobular breast cancer, is the sixth most frequently diagnosed cancer of women in the US with nearly 44,000 new patients diagnosed each year. 

Research indicates that ILC is a unique histological subtype of breast cancer with distinct biological and behavioral differences.

It’s time to advance research to better understand ILC and its differences and refine treatments for patients with lobular breast disease.

For Patients

Access the extensive resources we have compiled for individuals with invasive lobular carcinoma (ILC) and their loved ones.

ILC Clinical Trials

Help advance the understanding of ILC by participating in clinical trials.

Patients with invasive lobular carcinoma (ILC) can advance understanding of the disease by joining clinical trials. Few trials focus solely on ILC due to its lower incidence (10-15% of all breast cancers), but participation is crucial.

 Increased research could help improve detection, treatment, prevention of metastasis, and ultimately, develop a cure for people with ILC.

Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.